FILING RADAR

Connecting to SEC EDGAR… Pricing Sign in

← All filings

ALLO

Allogene Therapeutics, Inc. SEC filings

Biological Products, (No Diagnostic Substances) · Nasdaq

On the radar right now · 0

Nothing in the live feed for ALLO right now.

Filing history

2026-11-06

Quarterly report 10-Q

2026-11-05

Current report 8-K

Earnings results

2026-10-27

Passive 5%+ stake update SCHEDULE 13G/A

2026-10-23

Insider trade 4

2026-10-21

Planned insider sale 144

2026-09-30

5%+ stake update (13D) SCHEDULE 13D/A

2026-09-02

Current report 8-K

Exec/director change

2026-08-25

Insider trade 4

2026-08-21

Planned insider sale 144

2026-08-20

EFFECT EFFECT

2026-08-14

Passive 5%+ stake update SCHEDULE 13G/A

2026-08-12

Shelf registration (future share sales) S-3

2026-08-12

Quarterly report 10-Q

2026-08-12

Current report 8-K

Earnings results

2026-08-07

Passive 5%+ stake update SCHEDULE 13G/A

2026-08-07

Passive 5%+ stake SCHEDULE 13G

2026-07-06

Insider trade 4

2026-06-23

Insider trade 4

2026-06-23

Insider trade 4

2026-06-23

Insider trade 4

2026-06-23

Insider trade 4

2026-06-23

Insider trade 4

2026-06-23

Insider trade 4

2026-06-23

Insider trade 4

2026-06-22

Current report 8-K

Shareholder voteOther event

2026-06-22

Prospectus 424B5

2026-05-28

Proxy material DEFA14A

2026-05-28

Current report 8-K

Exec/director change

2026-05-21

Proxy material DEFA14A

2026-05-15

Passive 5%+ stake update SCHEDULE 13G/A

2026-05-15

Passive 5%+ stake update SCHEDULE 13G/A

2026-05-13

Passive 5%+ stake update SCHEDULE 13G/A

2026-05-13

Passive 5%+ stake update SCHEDULE 13G/A

2026-05-13

Quarterly report 10-Q

2026-05-13

Current report 8-K

Material agreementAgreement endedEarnings results

2026-04-30

Annual report to shareholders ARS

2026-04-30

Proxy material DEFA14A

2026-04-30

Proxy statement (shareholder vote) DEF 14A

2026-04-23

Passive 5%+ stake SCHEDULE 13G

2026-04-23

Insider trade 4